BioSpace News Archive

Biotech Beach

CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production

The company raised $7.5 M to establish world-class research facilities in the Southern California region and assemble an impressive scientific team.

April 16, 2019
·
1 min read
Business

Change Healthcare Research: 48 States Now Committed to Value-Based Care and Payment Models

National study finds states are acting to improve healthcare value by advancing a variety of value-based payment models that will drive the commercial market

April 16, 2019
·
3 min read
Pharm Country

bodySCULPT New York Launches New Groundbreaking AccuTite Procedure

Dr. Spero Theodorou and Dr. Christopher Chia Introduce Breakthrough AccuTite: One-Time Procedure, 15 Minute Treatment Time, Local Anesthesia, Minimal Downtime, Permanent Results

April 16, 2019
·
3 min read
Biotech Beach

BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market

First Conditionally Active Biologics licensing participation in Greater China territory

April 16, 2019
·
4 min read
FDA

Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)

Aprea Therapeutics announced that the U.S. Food and Drug Administration has granted Fast Track designation to APR-246 for the treatment of patients with MDS having a TP53 mutation.

April 16, 2019
·
4 min read
Policy

RepliCel Secures Several New Patents for its Regenerative Medicine Technologies

Tendon Regeneration, Skin Rejuvenation and Dermal Injector Patents Granted in the United States, Europe, South Africa, Hong Kong, China, and Japan

April 16, 2019
·
3 min read
Business

Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular conditions, announced the appointment of Paul Edick as Chairman of its Board of Directors.

April 16, 2019
·
2 min read
Deals

Canopy Growth Expands European Footprint, Acquires Spanish Licensed Cannabis Producer Cafina

Canopy Growth Corporation is pleased to announce that it has completed an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L..

April 16, 2019
·
6 min read
Drug Development

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

Aims to augment current cancer therapies by altering patients’ gut microbiome to improve response

April 16, 2019
·
5 min read
Business

Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer

Just two years since its founding by Flagship Labs, the company has elucidated a new understanding of the multimodal enteric system, translating this insight into 10+ therapeutic programs

April 16, 2019
·
8 min read